Patents by Inventor Scott Alban

Scott Alban has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110236406
    Abstract: The present invention relates to novel immunogenic compositions (e.g., vaccines), the production of such immunogenic compositions and methods of using such compositions. More specifically, this invention provides unique immunogenic molecules comprising an HMGB1 polypeptide (e.g., an HMGB1 B-box polypeptide) and an antigen. Even more specifically, this invention provides novel fusion proteins comprising an isolated HMGB1 polypeptide and an antigen such that administration of these fusion proteins provides the two signals required for native T-cell activation.
    Type: Application
    Filed: January 18, 2011
    Publication date: September 29, 2011
    Applicants: MedImmune, LLC, The Feinstein Institute for Medical Research
    Inventors: Davorka Messmer, Kevin Tracey, Peter Kiener, Scott Alban
  • Publication number: 20080305120
    Abstract: The present invention relates to novel immunogenic compositions (e.g., vaccines), the production of such immunogenic compositions and methods of using such compositions. More specially, this invention provides unique immunogenic molecules comprising an HMGB1 polypeptide (e.g., an HMGB1 B-box polypeptide) and an antigen. Even more specifically, this invention provides novel fusion proteins comprising an isolated HMGB1 polypeptide and an antigen such that administration of these fusion proteins provides the two signals required for native T-cell activation.
    Type: Application
    Filed: June 16, 2005
    Publication date: December 11, 2008
    Applicants: MEDIMMUNE, INC., THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
    Inventors: Davorka Messmer, Kevin Tracey, Peter Kiener, Scott Alban